🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Acute Promyelocytic Leukemia

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia NCT04793919Phase 231 sites📍 Brussels📍 Prague📍 Aarhus N Associazione Italiana Ematologia Oncologia Pediatrica · Tests: Mylotarg, Arsenic Trioxide, All-trans retinoic acid Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia NCT01409161Phase 25 sites📍 Houston📍 Houston📍 Nassau Bay M.D. Anderson Cancer Center · Tests: Arsenic Trioxide, Gemtuzumab Ozogamicin, Laboratory Biomarker Analysis, Tretinoin Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). NCT07503730Phase 31 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: ATRA, RIF, ATO Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... NCT02390752Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TURALIO(R) PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia NCT02390635Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Computed Tomography, Diffusion Weighted Imaging, Fludeoxyglucose F-18, Gadolinium, Magnetic Resonance Imaging RWE of 1st Line Treatment With ATO/ATRA for Adult APL NCT04897490n/a6 sites📍 La Plata📍 Paraná📍 Posadas Grupo Argentino de Tratamiento de la Leucemia Aguda · Tests: Evaluation of first line treatment with ATO/ATRA outcome Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia NCT07504458Phase 335 sites📍 Birmingham📍 Duarte📍 Irvine Quetzal Therapeutics · Tests: QTX-2101 + ATRA, IV arsenic trioxide (ATO) + ATRA Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia NCT06982274Phase 21 site📍 São Paulo Instituto do Cancer do Estado de São Paulo · Tests: Realgar-Indigo Naturalis Formulation Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia NCT05881265Phase 25 sites📍 Huai'an📍 Nanchang📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Chidamide+venetoclax
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy